WO1998036758A3 - Sauerstoffanionradikale enthaltende therapeutische mittel und deren verwendung zur behandlung von morbus parkinson - Google Patents

Sauerstoffanionradikale enthaltende therapeutische mittel und deren verwendung zur behandlung von morbus parkinson Download PDF

Info

Publication number
WO1998036758A3
WO1998036758A3 PCT/DE1998/000518 DE9800518W WO9836758A3 WO 1998036758 A3 WO1998036758 A3 WO 1998036758A3 DE 9800518 W DE9800518 W DE 9800518W WO 9836758 A3 WO9836758 A3 WO 9836758A3
Authority
WO
WIPO (PCT)
Prior art keywords
parkinson
disease
treatment
oxygen anion
therapeutic agents
Prior art date
Application number
PCT/DE1998/000518
Other languages
English (en)
French (fr)
Other versions
WO1998036758A2 (de
Inventor
Naum Goldstein
Original Assignee
Goldstein & Lewin Tech Gmbh
Naum Goldstein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goldstein & Lewin Tech Gmbh, Naum Goldstein filed Critical Goldstein & Lewin Tech Gmbh
Priority to AU68198/98A priority Critical patent/AU6819898A/en
Priority to CN98800497.6A priority patent/CN1222856A/zh
Priority to EA199800941A priority patent/EA001107B1/ru
Priority to EP98913515A priority patent/EP0910392A2/de
Publication of WO1998036758A2 publication Critical patent/WO1998036758A2/de
Publication of WO1998036758A3 publication Critical patent/WO1998036758A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Die Erfindung betrifft Sauerstoffanionradikale und/oder deren Folge- und Abbauprodukte enthaltende therapeutische Mittel und deren Verwendung zur Behandlung von Morbus Parkinson. Ziel ist in erster Linie die Verringerung bzw. Beseitigung des Tremors, der für Morbus Parkinson typisch ist, aber auch im Zusammenhang mit anderen Erkrankungen oder auch allein als 'seniler' Tremor auftreten kann.
PCT/DE1998/000518 1997-02-20 1998-02-17 Sauerstoffanionradikale enthaltende therapeutische mittel und deren verwendung zur behandlung von morbus parkinson WO1998036758A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU68198/98A AU6819898A (en) 1997-02-20 1998-02-17 Oxygen anion radicals and/or therapeutic preparations containing their reaction or breakdown products, and use of such preparations in the treatment of parkinson's disease
CN98800497.6A CN1222856A (zh) 1997-02-20 1998-02-17 含有氧阴离子基和/或其反应产物和分解产物的治疗药物及其应用于治疗帕金森氏病的用途
EA199800941A EA001107B1 (ru) 1997-02-20 1998-02-17 Терапевтические средства, содержащие кислородные анион-радикалы и/или продукты их последующего превращения и расщепления, и их применение для лечения болезни паркинсона
EP98913515A EP0910392A2 (de) 1997-02-20 1998-02-17 Sauerstoffanionradikale enthaltende therapeutische mittel und deren verwendung zur behandlung von morbus parkinson

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1997108643 DE19708643C2 (de) 1997-02-20 1997-02-20 Verwendung von Sauerstoffanionradikalen und/oder deren Folge- und Abbauprodukte zur Behandlung von Morbus Parkinson
DE19708643.8 1997-02-20

Publications (2)

Publication Number Publication Date
WO1998036758A2 WO1998036758A2 (de) 1998-08-27
WO1998036758A3 true WO1998036758A3 (de) 1998-12-23

Family

ID=7822112

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1998/000518 WO1998036758A2 (de) 1997-02-20 1998-02-17 Sauerstoffanionradikale enthaltende therapeutische mittel und deren verwendung zur behandlung von morbus parkinson

Country Status (7)

Country Link
EP (1) EP0910392A2 (de)
CN (1) CN1222856A (de)
AU (1) AU6819898A (de)
CA (1) CA2259986A1 (de)
DE (1) DE19708643C2 (de)
EA (1) EA001107B1 (de)
WO (1) WO1998036758A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10248601B4 (de) * 2002-10-17 2006-05-24 Goldstein, Naum, Dr.habil.nat. Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems
RU2253461C1 (ru) * 2004-04-30 2005-06-10 Общество с ограниченной ответственностью "Паркинфарм" Фармацевтическая комбинация, оказывающая влияние на функционирование цнс, способ коррекции состояний, связанных с нарушениями функционирования цнс; фармацевтический набор; средство, способствующее проникновению через гематоэнцефалический барьер лекарственных субстанций и метаболитов; фармацевтическое средство для эндоназального применения

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4112459A1 (de) * 1991-04-12 1992-10-15 Naum Dr Goldstein Verfahren und einrichtung zur erzeugung von definierten ionisierten gasen bzw. gasgemischen
CA2084725A1 (fr) * 1992-02-06 1994-06-08 Albert Roussy Solution therapeutique a usage externe

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4112459A1 (de) * 1991-04-12 1992-10-15 Naum Dr Goldstein Verfahren und einrichtung zur erzeugung von definierten ionisierten gasen bzw. gasgemischen
CA2084725A1 (fr) * 1992-02-06 1994-06-08 Albert Roussy Solution therapeutique a usage externe

Also Published As

Publication number Publication date
AU6819898A (en) 1998-09-09
EA001107B1 (ru) 2000-10-30
EP0910392A2 (de) 1999-04-28
CN1222856A (zh) 1999-07-14
EA199800941A1 (ru) 1999-06-24
DE19708643C2 (de) 1999-04-15
WO1998036758A2 (de) 1998-08-27
DE19708643A1 (de) 1998-08-27
CA2259986A1 (en) 1998-08-27

Similar Documents

Publication Publication Date Title
TNSN04113A1 (en) 3-â-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
TW225532B (de)
EP1820862A3 (de) Medizinische Präparate zur Behandlung von Alpha-Galaktosidase-A-Mangel
AU684059B2 (en) Application of riluzole in the treatment of Parkinson's disease and Parkinsonian syndromes
CA2165824A1 (fr) Utilisation du modafinil pour la fabrication d'un medicament ayant un effet sur les apnees du sommeil et les troubles ventilatoires d'origine centrale
CA2257133A1 (en) Human dnase i hyperactive variants
IL132293A0 (en) Use of lactoferin in the treatment of allergen induced disorders
TW362973B (en) Use of 2-anino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a composition having an antidepressant activity
GB9425730D0 (en) Compounds
WO1996022305A3 (en) Modified peptides
MY139368A (en) Novel cyclohexyl sulphones
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
PL310950A1 (en) Novel imidazole quinoxalinones, method of obtaining them and their application
WO1998036758A3 (de) Sauerstoffanionradikale enthaltende therapeutische mittel und deren verwendung zur behandlung von morbus parkinson
WO2002058532A3 (en) Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof
EP0273310A3 (de) 5-Aryl-3H-1,2,4-triazol-3-one und ihre Verwendung als Antikonvulsiva
AU7076494A (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
ZA924128B (en) New combination preparations for treatment of Parkinson's disease.
AU7230894A (en) Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
AU3881889A (en) Human interferon-gamma, process to prepare said human interferon-gamma, and its use
HUP0004647A2 (hu) Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására
AU5768298A (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
WO2000027881A3 (de) Menschliche interleukin -10 mutantenproteine

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 98800497.6

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AU BA CA CN CU CZ EE GE HU ID IL IS JP KG KP KR LK LR LT LV MD MG MK MN MX NO NZ PL RO SD SG SI SK TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1998913515

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 199800941

Country of ref document: EA

AK Designated states

Kind code of ref document: A3

Designated state(s): AU BA CA CN CU CZ EE GE HU ID IL IS JP KG KP KR LK LR LT LV MD MG MK MN MX NO NZ PL RO SD SG SI SK TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2259986

Country of ref document: CA

Ref document number: 2259986

Country of ref document: CA

Kind code of ref document: A

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1998913515

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09367184

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1998913515

Country of ref document: EP